These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 21894205

  • 1. Chemotherapy: Advanced Hodgkin lymphoma--balancing toxicity and cure.
    Lim SH, Johnson PW.
    Nat Rev Clin Oncol; 2011 Sep 06; 8(11):634-6. PubMed ID: 21894205
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of advanced stage Hodgkin lymphoma--it's all about risk-benefit.
    Phipps C, Lee YS, Hwang W.
    Br J Haematol; 2012 Oct 06; 159(1):113-5. PubMed ID: 22823109
    [No Abstract] [Full Text] [Related]

  • 5. Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
    Shankar A, Hayward J, Kirkwood A, McCarthy K, Hewitt M, Morland B, Daw S.
    Br J Haematol; 2014 May 06; 165(4):534-44. PubMed ID: 24754633
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Treatment of advanced Hodgkin lymphoma].
    Kreissl S, Borchmann P.
    Dtsch Med Wochenschr; 2013 Jun 06; 138(23):1212-4. PubMed ID: 23720173
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of Hodgkin lymphoma: a 50-year perspective.
    Canellos GP, Rosenberg SA, Friedberg JW, Lister TA, Devita VT.
    J Clin Oncol; 2014 Jan 20; 32(3):163-8. PubMed ID: 24441526
    [No Abstract] [Full Text] [Related]

  • 9. Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14).
    Gillessen S, Plütschow A, Fuchs M, Markova J, Greil R, Topp MS, Meissner J, Zijlstra JM, Eichenauer DA, Bröckelmann PJ, Diehl V, Borchmann P, Engert A, von Tresckow B.
    Lancet Haematol; 2021 Apr 20; 8(4):e278-e288. PubMed ID: 33770483
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Chemotherapy for Hodgkin's disease.
    Ekert H.
    N Engl J Med; 2003 Sep 18; 349(12):1186-7; author reply 1186-7. PubMed ID: 13679536
    [No Abstract] [Full Text] [Related]

  • 14. [Our experiences in treating patients with Hodgkin disease in the last decade].
    Simon Z, Keresztes K, Miltényi Z, Ress Z, Váróczy L, Vadász G, Gergely L, Illés A.
    Orv Hetil; 2007 Apr 15; 148(15):675-82. PubMed ID: 17416575
    [Abstract] [Full Text] [Related]

  • 15. ABMT recommended for relapsed Hodgkin's disease, but better overall survival not yet proved.
    Oncology (Williston Park); 1996 Apr 15; 10(4):593-4. PubMed ID: 8723294
    [No Abstract] [Full Text] [Related]

  • 16. Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.
    Merli F, Luminari S, Gobbi PG, Cascavilla N, Mammi C, Ilariucci F, Stelitano C, Musso M, Baldini L, Galimberti S, Angrilli F, Polimeno G, Scalzulli PR, Ferrari A, Marcheselli L, Federico M.
    J Clin Oncol; 2016 Apr 10; 34(11):1175-81. PubMed ID: 26712220
    [Abstract] [Full Text] [Related]

  • 17. Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group.
    Pfreundschuh MG, Schoppe WD, Fuchs R, Pflüger KH, Loeffler M, Diehl V.
    Cancer Treat Rep; 1987 Dec 10; 71(12):1203-7. PubMed ID: 2446751
    [Abstract] [Full Text] [Related]

  • 18. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of Hodgkin's disease.
    Ann Oncol; 2001 Sep 10; 12(9):1213-4. PubMed ID: 11697828
    [No Abstract] [Full Text] [Related]

  • 19. Is there a role for BEACOPP (bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, prednisone) in relapsed Hodgkin lymphoma?
    Eichenauer DA, Engert A.
    Leuk Lymphoma; 2009 Nov 10; 50(11):1733-4. PubMed ID: 19883301
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma.
    Bauer K, Skoetz N, Monsef I, Engert A, Brillant C.
    Cochrane Database Syst Rev; 2011 Aug 10; (8):CD007941. PubMed ID: 21833963
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.